Terms: = Gastric cancer AND HOXA13, P31271, 3209, ENSG00000106031, HOX1J, HOX1 AND Prognosis
4 results:
1. Clinicopathological and prognostic significance of octamer-binding transcription factor 4 in patients with gastric cancer: a systematic review and meta-analysis.
Wei Y; Liu H; Wang C; Zhang W; Wen X; Long H; Xu Z; Guo H; Liu Y; Wei D; Qiu C; Li G; Sun Z
Biomark Med; 2019 Feb; 13(3):219-234. PubMed ID: 30810340
[TBL] [Abstract] [Full Text] [Related]
2. hoxa13 contributes to gastric carcinogenesis through DHRS2 interacting with MDM2 and confers 5-FU resistance by a p53-dependent pathway.
Han Y; Song C; Wang J; Tang H; Peng Z; Lu S
Mol Carcinog; 2018 Jun; 57(6):722-734. PubMed ID: 29436749
[TBL] [Abstract] [Full Text] [Related]
3. Impact of homeobox genes in gastrointestinal cancer.
Joo MK; Park JJ; Chun HJ
World J Gastroenterol; 2016 Oct; 22(37):8247-8256. PubMed ID: 27729732
[TBL] [Abstract] [Full Text] [Related]
4. Identification and validation that up-expression of hoxa13 is a novel independent prognostic marker of a worse outcome in gastric cancer based on immunohistochemistry.
Han Y; Tu WW; Wen YG; Li DP; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
Med Oncol; 2013; 30(2):564. PubMed ID: 23592225
[TBL] [Abstract] [Full Text] [Related]
